 <h1>Jetrea Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>ocriplasmin ophthalmic</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about ocriplasmin ophthalmic. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Jetrea.</p><h2>In Summary</h2><p><b>More frequent side effects include:</b> decreased visual acuity and intraocular inflammation.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to ocriplasmin ophthalmic: intraocular solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, ocriplasmin ophthalmic (the active ingredient contained in Jetrea) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking ocriplasmin ophthalmic:</p><p>
<i>More common</i>
</p><ul>
<li>Bloody eyes</li>
<li>blurred vision or other change in vision</li>
<li>decreased vision</li>
<li>eye pain</li>
<li>redness of the eye</li>
<li>seeing flashes or sparks of light</li>
<li>sensitivity of the eye to light</li>
<li>tearing</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Change in color vision</li>
<li>difficulty seeing at night</li>
<li>eye discomfort</li>
<li>loss of vision</li>
<li>seeing floating spots before the eyes, or a veil or curtain appearing across part of vision</li>
<li>throbbing pain</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of ocriplasmin ophthalmic may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Dry eyes</li>
</ul><p>
<!-- end intraocular solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ocriplasmin ophthalmic: intravitreal solution</i></p><h3>General</h3><p>The most commonly reported side effects included vitreous floaters, eye pain, photopsia, and blurred vision.<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Vitreous floaters (up to 16.8%), macular hole (up to 15.8%), eye pain (up to 13.1%), photopsia (up to 11.8%), chromatopsia, conjunctival hemorrhage</p>
<p><b>Common</b> (1% to 10%): Abnormal optical coherence tomography (OCT), anterior chamber cell, anterior chamber flare, blurred vision, conjunctival edema, conjunctival hyperemia, cystoid macular edema, decreased best corrected visual acuity (BCVA), dry eye, dyschromatopsia, eye irritation, eye pruritus, eyelid edema, foreign body sensation in eyes, increased intraocular pressure, increased lacrimation, iritis, macular degeneration, macular edema, metamorphopsia, ocular discomfort, ocular hyperemia, photophobia, photopsia, reduced visual acuity, retinal breaks, retinal degeneration, retinal edema, retinal hemorrhage, retinal pigment epitheliopathy, subretinal fluid, visual impairment, vitreous detachment, vitreous hemorrhage, vitritis</p>
<p><b>Uncommon</b> (0.1% to 1%): Anterior chamber inflammation, conjunctival irritation, corneal abrasion, diplopia, eye inflammation, hyphema, lens subluxation, miosis, night blindness, retinal detachment, retinal tear, serious acute visual impairment, severe acute visual impairment, transient blindness, unequal pupils</p>
<p><b>Frequency not reported</b>: Dim vision, macular hole progression</p>
<p><b>Postmarketing reports</b>: Impaired pupillary reflex<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Abnormal color vision test, abnormal retinogram</p>
<p><b>Common</b> (1% to 10%): Abnormal macular reflex, increased intraocular pressure, visual field defect, visual symptoms perceived in the contralateral eye</p>
<p><b>Frequency not reported</b>: Scotoma<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Intravitreal injection procedure associated effects<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Immunogenicity<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Jetrea (ocriplasmin ophthalmic)." ThromboGenics Inc, Iselin, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Jetrea (ocriplasmin ophthalmic)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>En Espa√±ol</li>
<li>Drug class: miscellaneous ophthalmic agents</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Jetrea &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Vitreomacular Adhesion</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ocriplasmin ophthalmic: intravitreal solution</i></p><h3>General</h3><p>The most commonly reported side effects included vitreous floaters, eye pain, photopsia, and blurred vision.<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Vitreous floaters (up to 16.8%), macular hole (up to 15.8%), eye pain (up to 13.1%), photopsia (up to 11.8%), chromatopsia, conjunctival hemorrhage</p><p><b>Common</b> (1% to 10%): Abnormal optical coherence tomography (OCT), anterior chamber cell, anterior chamber flare, blurred vision, conjunctival edema, conjunctival hyperemia, cystoid macular edema, decreased best corrected visual acuity (BCVA), dry eye, dyschromatopsia, eye irritation, eye pruritus, eyelid edema, foreign body sensation in eyes, increased intraocular pressure, increased lacrimation, iritis, macular degeneration, macular edema, metamorphopsia, ocular discomfort, ocular hyperemia, photophobia, photopsia, reduced visual acuity, retinal breaks, retinal degeneration, retinal edema, retinal hemorrhage, retinal pigment epitheliopathy, subretinal fluid, visual impairment, vitreous detachment, vitreous hemorrhage, vitritis</p><p><b>Uncommon</b> (0.1% to 1%): Anterior chamber inflammation, conjunctival irritation, corneal abrasion, diplopia, eye inflammation, hyphema, lens subluxation, miosis, night blindness, retinal detachment, retinal tear, serious acute visual impairment, severe acute visual impairment, transient blindness, unequal pupils</p><p><b>Frequency not reported</b>: Dim vision, macular hole progression</p><p><b>Postmarketing reports</b>: Impaired pupillary reflex<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Abnormal color vision test, abnormal retinogram</p><p><b>Common</b> (1% to 10%): Abnormal macular reflex, increased intraocular pressure, visual field defect, visual symptoms perceived in the contralateral eye</p><p><b>Frequency not reported</b>: Scotoma<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Intravitreal injection procedure associated effects<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Immunogenicity<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Jetrea (ocriplasmin ophthalmic)." ThromboGenics Inc, Iselin, NJ. </p><h2>More about Jetrea (ocriplasmin ophthalmic)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>En Espa√±ol</li>
<li>Drug class: miscellaneous ophthalmic agents</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Jetrea &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Vitreomacular Adhesion</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>